QU
Qiming U.s. Ventures Management, LLC
High-turnover traderConcentrated strategyQuality / disciplined sizing
Total reported value
$55.6M
Reporting period: 2025-09-30 · Number of holdings: 4
QIMING U.S. VENTURES MANAGEMENT, LLC disclosed 4 holdings in its latest 13F filing for the period ending 2025-09-30, with total reported value of $55.6M and a quarterly turnover rate of 96.6%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 96.63
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 8
- Sizing Uniformity
- 88.26
Recent moves
Add TRML
0.0% $24.2M
Trim JSPR
0.0% -$1.8M
Add KRRO
0.0% $11.2M
Trim 2KZ0
0.0% -$81.2K
Sold out 43157M102
Sold out VTYXUSD
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TRML | Tourmaline Bio INC | Stock-Other | 63.76% | +14.93% | — | |
| 2 | KRRO | Korro Bio INC | Stock-Other | 31.68% | +3.94% | — | |
| 3 | JSPR | Jasper Therapeutics INC | Stock-Other | 3.97% | -13.32% | — | |
| 4 | 2KZ0 | Kezar Life Sciences INC | Stock-Other | 0.58% | -1.17% | — |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2025-09-30 | 4 | $55.6M | 97 | |
| 2025-06-30 | 6 | $23.6M | 0 | |
| 2025-03-31 | 6 | $23.1M | 0 | |
| 2024-12-31 | 6 | $51.1M | 0 | |
| 2024-09-30 | 6 | $51.4M | 0 | |
| 2024-06-30 | 6 | $52.6M | 0 | |
| 2024-03-31 | 6 | $89.7M | 0 | |
| 2023-12-31 | 8 | $109.2M | 0 | |
| 2023-09-30 | 7 | $75.3M | 0 | |
| 2023-06-30 | 7 | $95.2M | 0 | |
| 2023-03-31 | 7 | $82.6M | 0 | |
| 2022-12-31 | 7 | $75.6M | 0 | |
| 2022-09-30 | 7 | $68.8M | 0 | |
| 2022-06-30 | 7 | $72.0M | 0 | 145114M287410C3471871 |
| 2022-03-31 | 6 | $106.4M | 0 | 187410C245114M3471871 |
| 2021-12-31 | 6 | $217.3M | 0 | 145114M2471871387410C |
Holding changes this quarter
Qiming U.s. Ventures Management, LLC's most significant position changes for 2025-09-30: Sold out: Hillevax INC; Sold out: Ventyx Biosciences INC (VTYXUSD).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TRML | Tourmaline Bio INC | +14.9% | — | Unchanged |
| 2 | KRRO | Korro Bio INC | +3.9% | — | Unchanged |
| 3 | 2KZ0 | Kezar Life Sciences INC | -1.2% | — | Unchanged |
| 4 | JSPR | Jasper Therapeutics INC | -13.3% | — | Unchanged |
| 5 | ✓ | Hillevax INC | — | EXIT | Sold out |
| 6 | VTYXUSD | Ventyx Biosciences INC | — | EXIT | Sold out |
FAQ
What is Qiming U.s. Ventures Management, LLC and what type of investor is it?
Qiming U.s. Ventures Management, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2025-09-30), the firm manages a tracked equity portfolio valued at approximately $55.6M, spread across 4 disclosed positions.
What are Qiming U.s. Ventures Management, LLC's largest equity positions?
Based on the latest 13F filing, Qiming U.s. Ventures Management, LLC's top holdings by market value are:
1. Tourmaline Bio INC (TRML) — $35.5M (63.8%)
2. Korro Bio INC (KRRO) — $17.6M (31.7%)
3. Jasper Therapeutics INC (JSPR) — $2.2M (4.0%)
4. Kezar Life Sciences INC (2KZ0) — $323.2K (0.6%)
What changes did Qiming U.s. Ventures Management, LLC make in its most recent portfolio filing?
In the latest quarter, Qiming U.s. Ventures Management, LLC took a more defensive posture — trimming 0 positions and completely exiting 2 holdings. The largest of these moves: Sold out: Hillevax INC; Sold out: Ventyx Biosciences INC (VTYXUSD)
What sectors does Qiming U.s. Ventures Management, LLC focus on?
Sector breakdown data is not yet available for Qiming U.s. Ventures Management, LLC. Check back after the next 13F processing cycle.